Table 4.
Summary of the HHV8 genotype/subtype analysis
| Case | Tumour type | Genotype (K1 region) | Subtype (ORF26 region) | Subtype of M and P alleles |
| 1 | Classic KS | II/C | C | M |
| 2 | Classic KS | II/C | C | M |
| 3 | Classic KS | II/C | C | M |
| 4 | Classic KS | ND | C | M |
| 5 | Classic KS | ND | C | M |
| 6 | Classic KS | ND | C | M |
| 7 | Classic KS | ND | C | M |
| 8 | Classic KS | ND | C | M |
| 9 | AIDS KS | I/A | B | P |
| 10 | PEL | I/A | A | M |
| 11 | GP | II/C | C | M |
| Control | AIDS PEL | I/C | A | P |
Cases 1–11 are cases No. 1, 2, 3, 4, 5, 6, 7, 8, 9, 19 and 12 in table 3, respectively.
GP, granuloma pyogenicum; HHV8, human herpesvirus 8; KS, Kaposi’s sarcoma; ND, not determined; PEL, primary effusion lymphoma.